Risk of thrombotic events should not exclude transgender people from receiving hormone therapy, says new guidance
Medical Xpress
MARCH 6, 2023
The negative mental and physical effects of withholding gender-affirming hormone therapy (GAHT) from transgender people may outweigh the risk of GAHT-associated venous thromboembolism (VTE), underscoring the need for a thorough upfront discussion by healthcare provider and patient, according to a study led by investigators from Massachusetts General (..)
Let's personalize your content